Abstract:Abstract Purpose: We plan to use a tissue microarray-based microRNA(miRNA) detection by in situ hybridization with LNA probe and support vector machine on base of data mining to construct the Prognostic model for breast cancer and triple negative breast cancer (TNBC). Methods: Combining the BreastMark miRNA database and papers published, we chose candidate miRNAs. Then a tissue microarray-based miRNA detection in situ hybridization with LNA probe was used to detect miRNA expression in 445 breast cancer tissue. Univariate analysis with Kaplan-Meier identified independent prognostic factors, 445 patients was divided into the training set and validation set (70% VS 30%) by software R(version 3.2.3), then support vector machine on base of data mining was used to construct the Prognostic model for breast cancer and triple negative breast cancer via software R and predict.svm(e1071). Results: 15 miRNAs were detected from 445 breast cancer tissue and univariate analysis with Kaplan-Meier identified significant prognostic miRNAs: miR-361-5p, miR-301a, miR-223, miR-421, miR-454, miR-493 were the independent prognostic factors for DFS. By using data mining technique, we combined clinical factors(stage, tumor size, lymphnode status, molecular subtype) and miRNAs mentioned above to establish the personalized predictive mathematical models SVM-BC and SVM-TNBC. In the training set and validation set of SVM-BC model, the AUC value of ROC curve for DFS were 0.86,0.83. The total accuracy,sensitivity,specificity of SVM-BC model for DFS were 94%,73%,99% and 84%,57%,92% in the training set and validation set. The SVM-BC model can divide breast cancer patients into high-risk and low-risk groups, and 5-year survival rates for low-risk patients were higher than that for high-risk patients(96.8% VS 39.3%, p<0.001). In the training set and validation set of SVM-TNBC model, the AUC value of ROC curve for DFS were 0.84,0.86. The total accuracy,sensitivity,specificity of SVM-TNBC model for DFS were 90%,71%,97% and 84%,55%,94% in the training set and validation set. The SVM-TNBC model can divide breast cancer patients into high-risk and low-risk groups, and 5-year survival rates for low-risk patients were higher than that for high-risk patients(93.9 % VS 23.5%, p <0.001). Conclusion: The Prognostic model basing of tissue microarray-based miRNA detection in situ hybridization with LNA probe and support vector machine for prognosis can effectively predict the prognosis of breast cancer and TNBC. Citation Format: Cao Z, Yao L, Hu X, Zhang Z, Shao Z. In-situ hybridization of microRNA and support vector machines–based prognostic classifiers for breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P2-05-37.

Breast Tumor Diagnosis Based on Molecular Learning Vector Quantization Neural Networks

Breast Cancer Case Identification Based on Deep Learning and Bioinformatics Analysis

Identification of Gene Expression in Different Stages of Breast Cancer with Machine Learning

Assessing Breast Cancer Volume Alterations Post-Neoadjuvant Chemotherapy Through DenseNet-201 Deep Learning Analysis on DCE-MRI

BioDecoder: A miRNA Bio-interpretable Neural Network Model for Noninvasive Diagnosis of Breast Cancer

Quantum classical hybrid convolutional neural networks for breast cancer diagnosis

DNA Logic Circuits for Multiple Tumor Cells Identification Using Intracellular MicroRNA Molecular Bispecific Recognition

Abstract P2-05-37: In-situ Hybridization of Microrna and Support Vector Machines–based Prognostic Classifiers for Breast Cancer

Constructing a machine learning-based non-invasive liquid biopsy model for lung cancer detection via miRNA sequencing.

Raman spectroscopy and artificial intelligence to predict the Bayesian probability of breast cancer

DNA-framework-based multidimensional molecular classifiers for cancer diagnosis

Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes

DNA Logical Computing on a Transistor for Cancer Molecular Diagnosis

miRNA in Machine-Learning-Based Diagnostics of Oral Cancer

Brain Tumor Classification on MRI in Light of Molecular Markers

DNA-based molecular classifiers for the profiling of gene expression signatures

Convolutional Neural Networks For Predicting Molecular Profiles Of Non-Small Cell Lung Cancer

Ultrasensitive miRNA detection: A novel DNA nanomachine using split-type molecular beacons-mediated cascade amplification for cancer diagnostics

MiRS-HF: A Novel Deep Learning Predictor for Cancer Classification and miRNA Expression Patterns

Deep Learning for identifying radiogenomic associations in breast cancer

A Deep Learning Model for Predicting Molecular Subtype of Breast Cancer by Fusing Multiple Sequences of DCE-MRI From Two Institutes